New hope for pain relief in sickle cell disease

Trials of a new drug called Crizanlizumab offer hope of a breakthrough in pain relief for people with sickle cell disease – the most common of the congenital anaemias. For the CAN community, we plan a series of articles looking at the problems that patients experience and how research is improving understanding and treatment. In … Continue reading New hope for pain relief in sickle cell disease